BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3731547)

  • 1. Erythrocyte deformability in uremic hemodialyzed patients.
    Zachee P; Boogaerts MA; Lins RL; Van den Broeck ; De Broe ME
    Clin Nephrol; 1986 Jun; 25(6):315. PubMed ID: 3731547
    [No Abstract]   [Full Text] [Related]  

  • 2. Rheological properties of red blood cells (including reticulocytes) in patients with chronic renal disease.
    Nowak E; Wyrwicz G; Dabrowski Z; Smoleńiski O; Spodaryk K
    Clin Hemorheol Microcirc; 1999; 21(2):87-94. PubMed ID: 10599591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythrocyte deformability in acute and chronic kidney failure patients].
    Grinshteĭn IuI; Kalinina IA; Vitman TV
    Ter Arkh; 1986; 58(12):91-3. PubMed ID: 3824225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
    Docci D; del Vecchio C; Salvi P; Turci F; Salvi G; Cenciotti L; Pretolani E
    Clin Nephrol; 1985 Feb; 23(2):68-73. PubMed ID: 3987101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dialysis on erythrocyte membrane of chronically hemodialyzed patients.
    Ibrahim FF; Ghannam MM; Ali FM
    Ren Fail; 2002 Nov; 24(6):779-90. PubMed ID: 12472200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemorheological changes induced by uremia. Effects of hemodialysis].
    Delsignore R; David S; Francia MT; Bottazzi G; Crotti G
    Ric Clin Lab; 1985; 15 Suppl 1():335-45. PubMed ID: 4035225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of erythrocyte resistance to hemolysis and modification of membrane lipids induced by hemodialysis.
    Peuchant E; Salles C; Vallot C; Wone C; Jensen R
    Clin Chim Acta; 1988 Dec; 178(3):271-82. PubMed ID: 3240602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte deformability in uremic hemodialyzed patients.
    Forman S; Bischel M; Hochstein P
    Ann Intern Med; 1973 Dec; 79(6):841-3. PubMed ID: 4271555
    [No Abstract]   [Full Text] [Related]  

  • 9. Is erythrocyte damage prevented by gardos effect in hemodialyzed uremic patients?
    Agroyannis B; Paraskevopoulos A; Kopelias I; Tzanatos H; Kapetanaki A; Tsomi A
    Artif Organs; 2000 Sep; 24(9):743-5. PubMed ID: 11012545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolically conditioned erythrocyte rigidity in hemodialyzed uremic patients].
    Rosenmund A; Binswanger U; Straub PW
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1394. PubMed ID: 4417520
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid levels in hemodialyzed diabetic uremic patients.
    Carvounis CP; Feinfeld DA; Weinstein E; Lipner HI; Sadigali R; Avram MM
    N Y State J Med; 1981 Jun; 81(7):1053-6. PubMed ID: 6942246
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities--uremic toxin, small molecular compounds].
    Orita Y; Ando A
    Nihon Naika Gakkai Zasshi; 1986 Nov; 75(11):1545-9. PubMed ID: 2950190
    [No Abstract]   [Full Text] [Related]  

  • 13. Human erythropoietin improves the blood platelet phospholipid composition in chronically hemodialyzed patients.
    Krawczyk W; Dmoszyńska A; Marczewski K; Ledwozyw A
    Exp Nephrol; 1995; 3(4):265-6. PubMed ID: 8590040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on the early events of apoptosis in senescent erythrocytes with special emphasis on intracellular free calcium and loss of phospholipid asymmetry in chronic renal failure.
    Sakthivel R; Farooq SM; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2007 Jul; 382(1-2):1-7. PubMed ID: 17449019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal erythrocyte deformability in acute uremic rats.
    Kölbl H; Echsel H; Raneburger J; Vermes M; Hohenegger M
    Nephron; 1988; 48(3):261-2. PubMed ID: 3352862
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of middle molecules in uremic patients.
    Wu ZG; Cai ZH; Lu ZN; Liao LT; Zhu SQ
    Chin Med J (Engl); 1985 Feb; 98(2):115-20. PubMed ID: 3922688
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphate in uremic patients during and between hemodialysis.
    Hillion D; Haas T
    Clin Nephrol; 1994 Oct; 42(4):275. PubMed ID: 7695753
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transfusional therapy of hemodialyzed patient with anti-Cartwright antibodies: case report and review of the literature].
    Franchini M; Fabbian F; Piccoli PL; Gandini G; Aprili G; Loschiavo C; Lupo A
    G Ital Nefrol; 2004; 21(4):387-90. PubMed ID: 15526404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of the C3c complement in uremic patients hemodialyzed with three different dialyzer membranes, prior to the dialysis seance.
    Krawczyk W; Marczewski K; Ledwozyw A
    Clin Nephrol; 1995 Nov; 44(5):340. PubMed ID: 8605718
    [No Abstract]   [Full Text] [Related]  

  • 20. Is echinocytic transformation of erythrocytes related to lipid peroxidation in hemodialysed uraemic patients?
    Agroyannis B; Tzanatos H; Fourtounas C; Soubassi L; Kopelias I; Koutsikos D
    Clin Chim Acta; 1997 May; 261(2):185-7. PubMed ID: 9201438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.